Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO) commences share repurchases on July 18, 2023, under the program mandated by the shareholders in the Annual General Meeting held on April 27, 2023. As per the mandate, the company is authorized to repurchase up to 500,000 shares. The repurchases to be made such that the holding of company's shares should not exceed 10% of the share capital of the company. The price to be paid for repurchase should not deviate more than 20% on each side from the reference price that the stock will have recorded in the Stock Exchange session on the day preceding each individual transaction. The repurchased shares will be stored for subsequent use, used to regularize the performance of trading and prices and to support the liquidity of the security on the market, use to use to service future compensation and incentive plans, used to service any future programs for the free assignment of shares to Shareholders. The authorization will be valid till 18 months.

On June 8, 2023, the company announced a share repurchase program. The program will start on June 12, 2023 and will end on October 27, 2024.